Swedish biotech to test obesity drug on humans (Reuters)


Reuters - Swedish biotechnology firm Karo Bio
said on Monday it has begun phase I clinical trials of a drug
for treating obesity, a project which Bristol-Myers Squibb quit
last year.

Read more...